# Examples — Sample Outputs from Academic GStack Skills

> Real output format from each skill. Values and details are illustrative.

---

## Lit Reviewer

```
📚 Literature Review: nanomaterial-cell interaction mechanisms
Search time: 2026-06-01 23:05
Databases: arXiv, bioRxiv, PubMed | Time range: 2024-2026

📊 Search Overview
Searched: 23 | After dedup: 15 | Analyzed: 10 | High quality (≥35): 4

🏆 Top 3 Papers

| # | Title | Journal | Date | Score | Relevance | Novelty |
|---|-------|---------|------|-------|-----------|---------|
| 1 | Nanomaterials induce ferroptosis via GPX4 | ACS Nano | 2025 | 42 | 9 | 8 |
| 2 | Mitochondrial ROS in nanomaterial therapy | Small | 2024 | 38 | 8 | 7 |
| 3 | Particle size dictates death pathway | Nat Comm | 2025 | 36 | 7 | 9 |

🔬 #1 Deep Dive
Core hypothesis: Nanomaterials downregulate GPX4 → lipid peroxidation → ferroptosis
Untested corollary: Does mitochondrial lipid peroxidation precede GPX4 downregulation?
Relevance to your work: You have mitochondrial ROS data; they didn't look at mitochondria

🕳️ Research Gaps
| Gap | Importance | Competition | Your edge |
| Nano→mito lipid peroxidation→ferroptosis chain | 🔴 High | Low | TEM+ROS data |
```

---

## Hypothesis Generator

```
🧠 Hypothesis Report: nanomaterial cell death mechanism
Generated: 2026-06-02 | Based on: 10 papers | Debate rounds: 3

🏆 #1: Nanomaterial-induced mitochondrial lipid peroxidation triggers 
      ferroptosis via a GPX4-independent pathway

Debate summary:
Mechanist (A): Cristae loss + ROS + membrane rupture → classic ferroptosis morphology
Data-first (B): Annexin V- rules out apoptosis. But direct lipid peroxidation evidence missing
Analogist (C): Similar to erlotinib mechanism in TNBC — mitochondrial precedes cytosolic
Skeptic (D): How to exclude necroptosis? RIPK1/RIPK3/MLKL axis untested
→ Consensus: Hypothesis plausible but needs (a) lipid peroxidation probe 
             (b) Fer-1 rescue (c) GPX4 expression check

Verification:
Prediction A: C11-BODIPY signal increases at 2-4h → live-cell imaging
Prediction B: Fer-1 co-treatment rescues dose-dependently → dose-response
Prediction C: GPX4 protein level unchanged → Western blot
Falsification: If Fer-1 fails to rescue → ferroptosis hypothesis rejected
```

---

## Peer Reviewer

```
📝 Simulated Peer Review: nanomaterial-ferroptosis manuscript
Review time: 2026-06-03 | Target journal: ACS Nano

📊 Review Overview
| Reviewer | Role | Recommendation |
| #1 | Methodologist | Major Revision |
| #2 | Domain Expert | Minor Revision |
| #3 | Skeptic | Major Revision |

🔴 Critical Issues (≥2 reviewers agree)

F1: Missing necroptosis exclusion experiments
- #1: RIPK1/3/MLKL should be tested
- #3: "Ferroptosis is not the only non-apoptotic death"
→ Fix: Add Nec-1 control + RIPK3 immunoblot (est. 3 days)

📋 Revision Priority Matrix
| Priority | Issue | Effort |
| P0 | F1: Necroptosis exclusion | Med (3d) |
| P0 | F2: GPX4 activity assay | Low (1d) |
| P1 | I1: Overstated novelty claims in Discussion | Low (1h) |
```

---

## Journal Matcher

```
🎯 Journal Match Report: nanomaterial-ferroptosis
Match time: 2026-06-03

📊 Self-Assessment
Novelty: 7/10 | Methodology: 8/10 | Impact scope: Field-specific
Best-fit IF range: 12-18

🥇 Tier 1 (est. acceptance 15-25%)
| Journal | IF | Match | Est. Accept | Why |
| ACS Nano | 17 | 82% | ~20% | Recent similar nanotoxicity studies |
| Nano Letters | 11 | 75% | ~25% | Mechanistic detail sufficient |

🥈 Tier 2 (est. acceptance 25-35%) — RECOMMENDED
| Small | 13 | 78% | ~25% | Nano-bio interface is core scope |

🧭 Strategy B (Balanced): Small → if rejected → Nanoscale
Estimated total timeline: 4-6 months
```

---

## Data QA

```
🔍 Data Quality Audit: nanomaterial-ferroptosis
Audit time: 2026-06-03 | Total checks: 24 | Pass: 19 | Warn: 3 | Fatal: 2

🔴 Fatal (must fix before submission)
| F1 | Missing vehicle control | Fig 2A | DMSO used for erastin but no DMSO-only |
| F2 | n=2 for TEM quantification | Fig 1C | Minimum n=3 required |

🟡 Warnings
| W1 | n=3 for GPX4 WB | Fig 4C | Underpowered |
| W2 | Error bars = SEM but not stated | Fig 3B | Must label |

📊 Audit Summary
Completeness:    ████████░░ 82%
Statistics:      █████████░ 93%
Reproducibility: ██████░░░░ 65% ← lowest
Image integrity: ████████░░ 88%
```

---

## Lit Monitor

```
📡 Literature Monitor: 2026-05-26 ~ 06-01
Keywords: nanomaterials, ferroptosis, lipid peroxidation, cancer

🔴 CRITICAL
#1: "Size-dependent ferroptosis induction by nanomaterials"
    Source: bioRxiv, 2026-05-28
    Core finding: <10nm particles trigger ferroptosis; >10nm trigger apoptosis
    ⚠️ Overlap: They did the size-effect experiment you planned
    🎯 Response: Differentiate — they only did in vitro; you have in vivo data

📊 Weekly Stats
Total:          ██████████ 25
🔴 Critical:     ██ 2
🟡 Relevant:     █████ 5
🟢 Background:   ██████████████ 18
```

---

## Lab Manager

```
🏠 Lab Dashboard: 2026-06-01 (Monday)

⚡ Today's priority: Confirm C11-BODIPY data supports ferroptosis hypothesis

📋 Tasks
| # | Pri | Task | Project | Est |
| 1 | P0 | C11-BODIPY flow analysis | Nano-ferroptosis | 1h |
| 2 | P0 | Fer-1 rescue dose-response | Nano-ferroptosis | 2h |
| 3 | P1 | GPX4 Western blot | Nano-ferroptosis | 3h |
| 4 | P2 | Literature update check | All projects | 30m |

📊 Project Progress
| Project | Phase | Progress | Next |
| Nano-ferroptosis | 📊→✍️ | 75% | Launch Paper Drafter |
| Protein biophysics | 🔬 | 40% | Waiting for reagents |
| Plant photobiology | 📖 | 20% | Finish classification |
```
